59
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

      The Journal of Investigative Dermatology
      Animals, Antibodies, Monoclonal, pharmacology, Cells, Cultured, Cyclosporine, therapeutic use, Dermis, immunology, pathology, Gene Expression, drug effects, Humans, Immunosuppressive Agents, Interferon-gamma, genetics, Interleukin-17, metabolism, Interleukins, Keratin-16, Psoriasis, drug therapy, RNA, Messenger, Rats, Th1 Cells, classification

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The importance of T helper 17 (Th17) cells in inflammation and autoimmunity is now being appreciated. We analyzed psoriasis skin lesions and peripheral blood for the presence of IL-17-producing T cells. We localized Th17 cells predominantly to the dermis of psoriasis skin lesions, confirmed that IL-17 mRNA increased with disease activity, and demonstrated that IL-17 mRNA expression normalized with cyclosporine therapy. IL-22 mRNA expression mirrored IL-17 and both were downregulated in parallel with keratin 16. Th17 cells are a discrete population, separate from Th1 cells (which are also in psoriasis lesions), and Th2 cells. Our findings suggest that psoriasis is a mixed Th1 and Th17 inflammatory environment. Th17 cells may be proximal regulators of psoriatic skin inflammation, and warrant further attention as therapeutic targets.

          Related collections

          Author and article information

          Comments

          Comment on this article